Home › Heart Failure › Florida › Orlando
Heart Failure clinical trials in Orlando, FL
16 studies for Heart Failure are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecruitingPhase 3
- AdventHealth, Orlando
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecruitingPhase 3
- Clinical Site Partners, LLC, Winter Park · 5 mi away
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RecruitingPhase 3
- Clinical Site Partners, LLC, Winter Park · 5 mi away
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · 5 mi away
- and 1 more
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, Orlando
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
RecruitingPhase 1
- Flourish Research, Winter Park · 5 mi away
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Recruiting
- Advent Health, Orlando
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Recruiting
- Orlando Health, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi away
- K2 Medical Research, Maitland · 6 mi away
Alleviant ALLAY-HF Study
Recruiting
- Advent Health Orlando, Orlando
Assessment of CCM in HF With Higher Ejection Fraction
Recruiting
- AdventHealth Orlando, Orlando
- Revival Clinical Research, Orlando
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
RecruitingPhase 2
- AdventHealth Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi away
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
RecruitingPhase 2
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi away
CCM OPEN HF Registry
RecruitingObservational study
- AdventHealth Orlando, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
RecruitingPhase 3
- AdventHealth, Orlando
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY50 studies
- Boston, MA43 studies
- Dallas, TX43 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL32 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Durham, NC26 studies
- St. Louis, MO26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity29 studies
- Metastatic Cancer29 studies
- Alzheimer's Disease25 studies
- Cancer (all types)25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Major Depressive Disorder19 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.